DFCM
UTHR icon

Dark Forest Capital Management’s United Therapeutics UTHR Stock Holding History

Dark Forest Capital Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6,883
Closed -$3.35M – 1156
2025
Q4 		$3.35M Buy
6,883
+140
+2% +$65.2K 0.15% 202
2025
Q3 		$2.83M Buy
6,743
+5,240
+349% +$1.76M 0.11% 320
2025
Q2 		$432K Buy
1,503
+257
+21% +$76.8K 0.02% 962
2025
Q1 		$384K Sell
1,246
-284
-19% -$97.3K 0.02% 1005
2024
Q4 		$540K Buy
+1,530
New +$562K 0.08% 405
2024
Q3 		– Sell
-1,257
Closed -$400K – 1169
2024
Q2 		$400K Buy
+1,257
New +$333K 0.07% 339
2023
Q1 		– Sell
-11,431
Closed -$3.18M – 1500
2022
Q4 		$3.18M Buy
11,431
+11,407
+47,529% +$2.88M 0.78% 32
2022
Q3 		$5K Buy
+24
New +$5.37K ﹤0.01% 913
2022
Q2 		– Sell
-25
Closed -$4K – 1389
2022
Q1 		$4K Buy
25
+22
+733% +$4.19K ﹤0.01% 1139
2021
Q4 		$1K Sell
3
-80
-96% -$15.7K ﹤0.01% 1360
2021
Q3 		$15K Buy
+83
New +$16.3K 0.01% 904

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Dark Forest Capital Management's UTHR Position: Q1 2026 in Review

Dark Forest Capital Management sold out of United Therapeutics (UTHR) in Q1 2026, closing a stake of 6,883 shares — an estimated $3.35M sold.

Dark Forest Capital Management first reported a position in UTHR in Q3 2021 and held it in 11 quarters. The position peaked at $3.35M in Q4 2025. 854 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Dark Forest Capital Management reported no remaining United Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Dark Forest Capital Management sold 6,883 United Therapeutics shares in Q1 2026, an estimated $3.35M.
  • Dark Forest Capital Management first reported a position in United Therapeutics in Q3 2021 and held it in 11 quarters.
  • Dark Forest Capital Management's United Therapeutics position peaked at $3.35M in Q4 2025.
  • 854 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Dark Forest Capital Management's 13F filing for Q1 2026, filed 15 May 2026.